Anzeige
Mehr »
Login
Donnerstag, 20.06.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Warum diese Aktie jetzt massiv durchstartet und wie Sie zu neuen Gratis-Aktien kommen…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14NKG | ISIN: US46185L1035 | Ticker-Symbol: N/A
Frankfurt
05.02.24
19:40 Uhr
0,110 Euro
0,000
0,00 %
1-Jahres-Chart
INVITAE CORPORATION Chart 1 Jahr
5-Tage-Chart
INVITAE CORPORATION 5-Tage-Chart

Aktuelle News zur INVITAE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.05.Invitae Receives Court Approval for Sale to Labcorp296Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Invitae (OTC:NVTAQ), a leading medical genetics company, announced today that the United States Bankruptcy...
► Artikel lesen
02.05.Invitae Corp - 8-K, Current Report8
28.04.Labcorp Makes Another Acquisition, Plucking Invitae Assets From Bankruptcy Auction12
26.04.Labcorp picks up Invitae portfolio for $239M in bankruptcy sale10
25.04.Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal7
25.04.Labcorp wins bid to acquire select Invitae assets for $239 mln3
25.04.Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 million2
25.04.Labcorp Wins Bid To Acquire Invitae Assets For $239 Mln Plus Non-Cash Considerations360WASHINGTON (dpa-AFX) - Invitae said that Labcorp (LH) has emerged as the successful bidder in the company's auction during its sale process under Section 363 of the U.S. Bankruptcy Code. Labcorp...
► Artikel lesen
25.04.Invitae Corporation: Invitae Enters into Agreement with Labcorp for Sale of Business279- Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals - - $239 Million Cash Bid Includes Acquisition of Substantially All of the Company's...
► Artikel lesen
04.04.Invitae Corp - 8-K, Current Report32
06.03.Invitae Corp - 8-K, Current Report36
06.03.Invitae reports Q4 results36
06.03.Invitae Corporation: Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Results351SAN FRANCISCO, March 6, 2024 /PRNewswire/ -- Invitae (OTC: NVTA), a leading medical genetics company, today announced estimated unaudited fourth quarter and full year 2023 revenue, gross profit...
► Artikel lesen
21.02.NSE - Invitae Corp - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities65
15.02.Invitae gets court approval for five-month bankruptcy sale81
14.02.Invitae prepares for a sale as it files for Chapter 11 bankruptcy25
14.02.Invitae Corp - 8-K, Current Report7
14.02.Invitae files for Chapter 11 bankruptcy to address huge debt load14
14.02.Genetic test maker Invitae files for bankruptcy protection in US12
14.02.Genetic Testing Firm Invitae, Backed by SoftBank and Cathie Wood, Files for Chapter 1131
Seite:  Weiter >>
46 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3